Larvol Delta - MASIMS-Masitinib-in-the-Treatment-of-Patients-With-Primary-Progressive-or-Nonactive-Secondary-Progressive-Multiple-Sclerosis

Kinaction (masitinib) - AB Science

http://clinicaltrials.gov/ct2/show/NCT05441488

May 7, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next